Substance Misuse Archives | Page 20 of 37 | Center for U.S. Policy

Let's Ease Restrictions on Buprenorphine for OUD

Let’s Ease Restrictions on Buprenorphine for OUD

Third-Party Opinion March 5, 2020

DEA Issues Proposed Rule to Expand Access to Mobile Opioid Treatment

DEA Issues Proposed Rule to Expand Access to Mobile Opioid Treatment

News March 4, 2020

Opioid Litigation Flouts Democratic Process

Opioid Litigation Flouts Democratic Process

Third-Party Opinion February 26, 2020

DEA Announces Improvements to MAT

DEA Announces Improvements to MAT

News February 26, 2020

U.S. Rep Hartzler: GAO Should Audit Opioid Spending

U.S. Rep Hartzler: GAO Should Audit Opioid Spending

Third-Party Opinion January 27, 2020

ACLU Sues To Protect Patient Privacy in Opioid Lawsuits

ACLU Sues To Protect Patient Privacy in Opioid Lawsuits

News January 25, 2020

Maine Groups Propose 20 MAT Bridge Clinics

Maine Groups Propose 20 MAT Bridge Clinics

News January 24, 2020

Barriers to Medicaid Beneficiaries' Access to OUD Medications

Barriers to Medicaid Beneficiaries’ Access to OUD Medications

External Report January 24, 2020

U.S. Reps Request GAO Audit of Opioid Spending

U.S. Reps Request GAO Audit of Opioid Spending

News January 24, 2020

Buprenorphine Provider Database Inaccurate

Buprenorphine Provider Database Inaccurate

News January 23, 2020